ATE538120T1 - Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazole - Google Patents
Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazoleInfo
- Publication number
- ATE538120T1 ATE538120T1 AT08759157T AT08759157T ATE538120T1 AT E538120 T1 ATE538120 T1 AT E538120T1 AT 08759157 T AT08759157 T AT 08759157T AT 08759157 T AT08759157 T AT 08759157T AT E538120 T1 ATE538120 T1 AT E538120T1
- Authority
- AT
- Austria
- Prior art keywords
- regioselective
- azabenzimidazoles
- benzimidazoles
- metal
- annated
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- -1 N-substituted benzimidazoles Chemical class 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Measuring Oxygen Concentration In Cells (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290801 | 2007-06-26 | ||
| PCT/EP2008/004638 WO2009000412A1 (en) | 2007-06-26 | 2008-06-11 | A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE538120T1 true ATE538120T1 (de) | 2012-01-15 |
Family
ID=39720505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08759157T ATE538120T1 (de) | 2007-06-26 | 2008-06-11 | Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazole |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100216988A1 (enExample) |
| EP (1) | EP2173747B1 (enExample) |
| JP (1) | JP5492769B2 (enExample) |
| KR (1) | KR20100033484A (enExample) |
| CN (1) | CN101687865A (enExample) |
| AT (1) | ATE538120T1 (enExample) |
| AU (1) | AU2008267443A1 (enExample) |
| BR (1) | BRPI0813273A2 (enExample) |
| CA (1) | CA2693142A1 (enExample) |
| IL (1) | IL202822A0 (enExample) |
| WO (1) | WO2009000412A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008520744A (ja) | 2004-11-19 | 2008-06-19 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 抗炎症性ピラゾロピリミジン |
| DK2004654T3 (da) | 2006-04-04 | 2013-07-22 | Univ California | Pyrazolopyrimidin derivater til anvendelse som kinase antagonister |
| WO2009046448A1 (en) | 2007-10-04 | 2009-04-09 | Intellikine, Inc. | Chemical entities and therapeutic uses thereof |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| KR101660050B1 (ko) | 2008-01-04 | 2016-09-26 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
| WO2009114874A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Benzothiazole kinase inhibitors and methods of use |
| WO2009114870A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Kinase inhibitors and methods of use |
| US20110224223A1 (en) | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof |
| EP3009436B1 (en) | 2008-07-08 | 2019-06-05 | Intellikine, LLC | Kinase inhibitors and methods of use |
| CA2738429C (en) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
| ES2570429T3 (es) | 2008-10-16 | 2016-05-18 | Univ California | Inhibidores de heteroaril quinasa de anillo condensado |
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| JP2010235575A (ja) * | 2009-03-09 | 2010-10-21 | Konica Minolta Holdings Inc | 含窒素縮合複素環化合物の製造方法 |
| CA2760791C (en) | 2009-05-07 | 2017-06-20 | Intellikine, Inc. | Heterocyclic compounds and uses thereof |
| US8691809B2 (en) | 2009-08-18 | 2014-04-08 | Ventirx Pharmaceuticals, Inc. | Substituted benzoazepines as toll-like receptor modulators |
| EP3159337A3 (en) | 2009-08-18 | 2017-07-26 | Ventirx Pharmaceuticals, Inc. | Substituted benzoazepines as toll-like receptor modulators |
| WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
| EP2571357B1 (en) | 2010-05-21 | 2016-07-06 | Infinity Pharmaceuticals, Inc. | Chemical compounds, compositions and methods for kinase modulation |
| WO2012061342A2 (en) | 2010-11-01 | 2012-05-10 | Arqule, Inc. | Substituted benzo-imidazo-pyrido-diazepine compounds |
| WO2012064973A2 (en) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| RS53768B1 (sr) * | 2010-12-16 | 2015-06-30 | F. Hoffmann-La Roche Ag. | Triciklična pi3k inhibitorna jedinjenja i postupci korišćenja |
| NZ612909A (en) | 2011-01-10 | 2015-09-25 | Infinity Pharmaceuticals Inc | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
| JP6130305B2 (ja) | 2011-02-23 | 2017-05-17 | インテリカイン， エルエルシー | キナーゼ阻害剤の組み合わせおよびそれらの使用 |
| CN103930422A (zh) | 2011-07-19 | 2014-07-16 | 无限药品股份有限公司 | 杂环化合物及其用途 |
| AR088218A1 (es) | 2011-07-19 | 2014-05-21 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos utiles como inhibidores de pi3k |
| AU2012302197B2 (en) | 2011-08-29 | 2016-01-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
| JP6342805B2 (ja) | 2011-09-02 | 2018-06-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 置換ピラゾロ［３，４−ｄ］ピリミジンおよびその用途 |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| WO2014052669A1 (en) | 2012-09-26 | 2014-04-03 | The Regents Of The University Of California | Modulation of ire1 |
| MX386085B (es) | 2012-11-01 | 2025-03-18 | Infinity Pharmaceuticals Inc | Tratamiento de canceres utilizando moduladores de las isoformas de pi3 cinasa |
| US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US9359365B2 (en) | 2013-10-04 | 2016-06-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CN106456628A (zh) | 2014-03-19 | 2017-02-22 | 无限药品股份有限公司 | 用于治疗PI3K‑γ介导的障碍的杂环化合物 |
| US20150320755A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| CN105017257B (zh) * | 2014-04-30 | 2017-05-24 | 华东理工大学 | 四氢茚并吡咯并咪唑的衍生物及其制备方法和用途 |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| KR101540198B1 (ko) * | 2015-01-29 | 2015-07-29 | 성균관대학교산학협력단 | 팔라듐이 함유된 카본 나이트라이드 지지체를 이용한 메탄올과 일산화탄소의 카르보닐레이션 반응으로부터 아세트산을 제조하기 위한 촉매 및 이의 제조방법 |
| CA2980159A1 (en) * | 2015-03-18 | 2016-09-22 | Bristol-Myers Squibb Company | Substituted tricyclic heterocyclic compounds |
| CA2998469C (en) | 2015-09-14 | 2025-12-09 | Twelve Therapeutics, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
| US20180319813A1 (en) * | 2015-11-04 | 2018-11-08 | Idemitsu Kosan Co., Ltd | Benzimidazole fused heteroaryls |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| CN105968044A (zh) * | 2016-05-11 | 2016-09-28 | 张加明 | 一种乙氧基喹啉的工业化生产方法 |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| BR112018077021A2 (pt) | 2016-06-24 | 2019-04-02 | Infinity Pharmaceuticals, Inc. | terapias de combinação |
| CN110003213B (zh) * | 2018-01-04 | 2021-10-08 | 南京农业大学 | 苯并咪唑并三嗪酮类化合物、制备方法及应用 |
| CN111217819B (zh) * | 2018-11-27 | 2021-05-14 | 杭州科巢生物科技有限公司 | 乌帕替尼的合成方法 |
| TWI804079B (zh) * | 2019-05-09 | 2023-06-01 | 瑞士商赫孚孟拉羅股份公司 | 經標記之咪唑并[1,2-a]嘧啶之合成 |
| CN110681362B (zh) * | 2019-09-26 | 2020-09-11 | 浙江大学 | 以羧基和吲哚基为功能基团的混合模式层析介质 |
| PE20230608A1 (es) | 2020-05-05 | 2023-04-13 | Nuvalent Inc | Quimioterapicos de eter macrociclico heteroaromatico |
| WO2021226269A1 (en) | 2020-05-05 | 2021-11-11 | Nuvalent, Inc. | Heteroaromatic macrocyclic ether chemotherapeutic agents |
| CN112552305B (zh) * | 2020-11-26 | 2021-11-30 | 广东省测试分析研究所（中国广州分析测试中心） | 一种苯并环庚烷并咪唑并吡啶类阻燃抗紫外线分子材料及其制备方法与应用 |
| CN113512068B (zh) * | 2021-04-13 | 2022-05-31 | 山西大学 | 一种双配体的亚硝酰钌配合物及其制备方法和应用 |
| WO2023056441A1 (en) * | 2021-09-30 | 2023-04-06 | Prelude Therapeutics Incorporated | Cdk inhibitors and their use as pharmaceuticals |
| KR20240087788A (ko) | 2021-10-01 | 2024-06-19 | 뉴베일런트, 아이엔씨. | 헤테로방향족 매크로사이클릭 에테르 화합물의 고체 형태, 약학 조성물 및 제조 |
| CN114907421A (zh) * | 2022-06-06 | 2022-08-16 | 河南师范大学 | 铑催化6-芳基嘌呤核苷和炔烃合成荧光多环嘌呤盐的方法 |
| CN116943408B (zh) * | 2023-06-30 | 2024-01-30 | 江苏创新石化有限公司 | 一种位阻胺复合脱硫剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049422A (en) * | 1976-03-29 | 1977-09-20 | United States Borax & Chemical Corporation | Herbicidal morpholinobenzimidazoles |
| SU1587052A1 (ru) * | 1988-06-27 | 1990-08-23 | Всесоюзный научно-исследовательский институт химических средств защиты растений | Способ получени 2,3-дигидро-1Н-пирроло [1,2- @ ]бензимидазол-6-сульфонамидов |
| DE69332736T2 (de) * | 1992-12-07 | 2004-03-25 | Eisai Co., Ltd. | Verfahren zur herstellung von imidazopyridinderivaten und zwischenprodukte |
| CA2464109A1 (en) * | 2001-10-18 | 2003-12-24 | Michigan State University | Process for the preparation of oxazolidinones and method of use thereof |
| WO2006058064A2 (en) | 2004-11-29 | 2006-06-01 | Merck & Co., Inc. | Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
-
2008
- 2008-06-11 CN CN200880022154A patent/CN101687865A/zh active Pending
- 2008-06-11 BR BRPI0813273-9A2A patent/BRPI0813273A2/pt not_active IP Right Cessation
- 2008-06-11 JP JP2010513709A patent/JP5492769B2/ja not_active Expired - Fee Related
- 2008-06-11 EP EP08759157A patent/EP2173747B1/en not_active Not-in-force
- 2008-06-11 AU AU2008267443A patent/AU2008267443A1/en not_active Abandoned
- 2008-06-11 CA CA2693142A patent/CA2693142A1/en not_active Abandoned
- 2008-06-11 WO PCT/EP2008/004638 patent/WO2009000412A1/en not_active Ceased
- 2008-06-11 AT AT08759157T patent/ATE538120T1/de active
- 2008-06-11 KR KR1020097026783A patent/KR20100033484A/ko not_active Withdrawn
-
2009
- 2009-12-17 IL IL202822A patent/IL202822A0/en unknown
- 2009-12-22 US US12/644,379 patent/US20100216988A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2693142A1 (en) | 2008-12-31 |
| KR20100033484A (ko) | 2010-03-30 |
| CN101687865A (zh) | 2010-03-31 |
| IL202822A0 (en) | 2010-06-30 |
| AU2008267443A1 (en) | 2008-12-31 |
| US20100216988A1 (en) | 2010-08-26 |
| EP2173747B1 (en) | 2011-12-21 |
| JP5492769B2 (ja) | 2014-05-14 |
| WO2009000412A1 (en) | 2008-12-31 |
| EP2173747A1 (en) | 2010-04-14 |
| BRPI0813273A2 (pt) | 2014-12-30 |
| JP2010531312A (ja) | 2010-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE538120T1 (de) | Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazole | |
| ATE539063T1 (de) | Regioselektive, kupferkatalysierte synthese von benzimidazolen und azabenzimidazolen | |
| NO20090264L (no) | En regioselektiv palladiumkatalysert syntese av benzimidazoler og azabenzimidazoler | |
| ATE553093T1 (de) | Indazolderivate zur hemmung von trpv1 und verwendungen davon | |
| MA33776B1 (fr) | Dérivés arylecarbonyle et hétéroarylcarbonyle d'hexahydroindénopyridine et d'octahydrobenzoquinoline | |
| MX2009004441A (es) | Derivados de indazol utiles como inhibidores de las isoformas de higado. | |
| IL189194A (en) | Benzimidazoles are conserved as kinase inhibitors and their use in the preparation of cancer drugs | |
| TW200942533A (en) | Pyridyl inhibitors of hedgehog signalling | |
| NO20083726L (no) | Spiroindolinon derivater | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| FR2904830B1 (fr) | Procede de production de gaz de synthese avec oxydation partielle et vaporeformage | |
| ATE500222T1 (de) | Benzamid- und heteroarenderivate als cetp- inhibitoren | |
| ATE511501T1 (de) | Übergangsmetallkatalysierte synthese von 2h- indazolen | |
| UA107784C2 (en) | Inhibitor of melanin production | |
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| MX2008012332A (es) | Tiazolil-dihidro-indazoles. | |
| ATE483685T1 (de) | 1-benzensulfonyl-1h-indol-derivate als hemmer der ccr9-aktivität | |
| MX2009000480A (es) | Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios. | |
| MX2010004498A (es) | Derivados de ciclohexenoamida y su uso como antagonistas de trpv1. | |
| JO2734B1 (en) | Organic compounds | |
| NL1034604A1 (nl) | Verwijdering van waterstofcyanide uit synthesegas. | |
| BRPI0812829A2 (pt) | Processo para o acoplamento catalisado por paládio de alcinas terminais com tosilatos de arila | |
| DE602006010540D1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor | |
| EA201200726A1 (ru) | Способ синтеза, кристаллическая форма 4-{3-[цис-гексагидроциклопента[c]пиррол-2(1н)ил]пропокси}бензамид гидрохлорида и фармацевтические композиции, которые ее содержат | |
| MX2011009886A (es) | Derivados de amida como ligandos del receptor y5 del neuropeptido. |